Schedule 25 [LS16] Strategies for First-line treatment of ALK-positive non-small cell lung cancer ○Myung-Ju Ahn (Division of Hemato-Oncology Department of Medicine Samsung Medical Center Sungkyunkwan University School of Medicine, Korea)
